Skip to content
Back to Investors
Breega

Breega

Venture Capital

Breega is an international venture capital firm with over €600m in assets under management that invests in pioneering and purpose-driven founders from pre-seed to Series A and beyond.

Portfolio

8

companies

AUM

£260M

under management

Investment by month

By category

  • FinTech£119M
  • PropTech£15.0M
  • Satellites£9.8M
  • InsurTech£9.0M
  • BioTech£3.0M
  • Other£2.3M

By location

  • United Kingdom£95.0M
  • London£63.1M

Portfolio companies

B

BioOrbit

BioOrbit manufactures drug crystals in space to improve cancer therapies.

CC

Cori Clinical

AI workspace designed to reduce clinical trial protocol amendments and set-up costs.

G

Griffin

Griffin provides full-stack Banking as a Service infrastructure for financial technology companies.

Keebo

Keebo

Keebo offers a credit card and mobile application designed to improve financial wellness and build credit history.

M

Moneybox

Moneybox operates a digital wealth management application for saving, investing, and retirement planning.

O

Osu

Osu builds a payment application that helps the self-employed manage transactions and invoicing.

View all 8 companies

Team

BM

Ben Marrel

Co-founder & CEO

LinkedIn
MD

Maxence Drummond

VC Principal

Maxence brings venture capital experience from Breega, alongside operating experience as cofounder and CEO at malibou.

LinkedIn
Dan Shellard

Dan Shellard

Partner

Dan brings operating and investment experience from Google, Qubit, Fiit, and Breega.

LinkedIn
MV

Matthieu Vallin

Partner


Recent investments

Seed
$4.0M

The round was led by Breega to support delivery capacity and team growth.

"Clinical trials are built through a series of interconnected decisions about how a study should be designed and run. Today, much of the knowledge and precedent behind those decisions is scattered across previous trials, siloed teams, internal systems and separate documents. Cori brings that intelligence together into a living blueprint, so teams can make better-informed decisions before avoidable problems become delays, so the science never waits on the process,"
— Jorn Jansen Schoonhoven, Investor
Series A
£19.0M

The funding follows regulatory approval for the Banking as a Service platform to exit mobilisation.

"This pivotal moment is only possible because of the support of our investors, the guidance from our regulators and the commitment of our people. A big thank you to all our existing investors and a warm welcome to all our new investors. We look forward to working with all our investors in this exciting new chapter for Griffin"
— John Weguelin, Board Chair
Series A
£9.0M

Breega and Mercia backed the InsurTech firm to accelerate growth in the UK and US markets.

"Send has the most advanced underwriting workbench on the market and a proven track record of improving underwriting processes. The funding will enable us to build on our first-mover advantage, scale up the business and establish Send as the market-leading underwriting software platform."
— Andy Moss, Co-founder and CEO
Series D+
£35.0M

The digital wealth manager has raised £35m from a syndicate led by Fidelity International Strategic Ventures to expand its product range.

"Our mission is to help people build wealth with confidence so they can enjoy life today and tomorrow. This new round of investment enables us to create even better services to help our customers succeed across their home-buying, retirement, savings and investing missions. By continuing to focus on the large and under-served mass market we believe we are on a path to create the UK’s category-defining wealth platform. We celebrate this moment with deep gratitude for our amazing team, our loyal customers, and our supportive investors."
— Ben Stanway, Co-Founder and Executive Chair